Vitiligo Clinical Trials in Guangzhou, Guangdong
2 recruitingGuangzhou, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
Vitiligo
Pfizer400 enrolled74 locationsNCT06163326
Recruiting
Phase 2Phase 3
ICP-332 in Subjects With Non-segmental Vitiligo
Non-segmental Vitiligo
Beijing InnoCare Pharma Tech Co., Ltd.603 enrolled45 locationsNCT07047612